Avalo Therapeutics, Inc. revenue breakdown overview

Avalo Therapeutics, Inc. revenue for the last year amounted to 1.92 M USD, the most of which — 1.41 M USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 3.36 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Avalo Therapeutics, Inc. 1.92 M USD, and the year before that — 18.05 M USD.